Markus Rojewski

5.3k total citations
83 papers, 3.4k citations indexed

About

Markus Rojewski is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Markus Rojewski has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 21 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Markus Rojewski's work include Mesenchymal stem cell research (33 papers), Periodontal Regeneration and Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Markus Rojewski is often cited by papers focused on Mesenchymal stem cell research (33 papers), Periodontal Regeneration and Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Markus Rojewski collaborates with scholars based in Germany, United States and France. Markus Rojewski's co-authors include Hubert Schrezenmeier, Natalie Fekete, Anita Ignatius, Donald Bunjes, Anita Schmitt, Michael Schmitt, Hartmut Döhner, Julia Dausend, Jochen Greiner and Karin Scharffetter‐­Kochanek and has published in prestigious journals such as Nature Genetics, Blood and The Journal of Immunology.

In The Last Decade

Markus Rojewski

81 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Rojewski Germany 32 1.2k 1.1k 881 732 605 83 3.4k
Johannes Fischer Germany 31 633 0.5× 756 0.7× 631 0.7× 836 1.1× 646 1.1× 135 2.9k
Nathalie Meuleman Belgium 36 2.0k 1.7× 1.3k 1.2× 748 0.8× 645 0.9× 721 1.2× 98 3.7k
Jim Middleton United Kingdom 25 1.7k 1.4× 1.2k 1.1× 826 0.9× 212 0.3× 940 1.6× 36 4.1k
Pascale Louis‐Plence France 29 1.9k 1.6× 1.2k 1.2× 1.3k 1.5× 240 0.3× 737 1.2× 53 4.1k
Frédéric Deschaseaux France 29 1.9k 1.6× 1.1k 1.1× 593 0.7× 236 0.3× 484 0.8× 55 3.4k
Liza J. Raggatt Australia 20 505 0.4× 1.7k 1.6× 966 1.1× 659 0.9× 879 1.5× 34 3.7k
Alain Chapel France 28 2.2k 1.8× 940 0.9× 371 0.4× 396 0.5× 715 1.2× 67 3.6k
Florence Apparailly France 43 2.0k 1.7× 2.8k 2.6× 1.4k 1.6× 440 0.6× 1.1k 1.9× 119 6.5k
Laurence Lagneaux Belgium 43 3.4k 2.8× 2.1k 2.0× 1.2k 1.4× 599 0.8× 960 1.6× 135 5.8k
Dirk Strunk Austria 42 2.6k 2.1× 2.2k 2.0× 903 1.0× 757 1.0× 663 1.1× 121 5.8k

Countries citing papers authored by Markus Rojewski

Since Specialization
Citations

This map shows the geographic impact of Markus Rojewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Rojewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Rojewski more than expected).

Fields of papers citing papers by Markus Rojewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Rojewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Rojewski. The network helps show where Markus Rojewski may publish in the future.

Co-authorship network of co-authors of Markus Rojewski

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Rojewski. A scholar is included among the top collaborators of Markus Rojewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Rojewski. Markus Rojewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanz, Mariano, Cecilie Gjerde, Bjørn Tore Gjertsen, et al.. (2025). Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial. Clinical Oral Implants Research. 36(11). 1498–1514. 1 indexed citations
2.
Krutzke, Lea, Markus Rojewski, Philip H. Zeplin, et al.. (2023). Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas. Viruses. 15(1). 218–218. 3 indexed citations
3.
Popp, Tanja, Matthias Port, Sebastian Wiese, et al.. (2023). Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells. Cells. 12(16). 2105–2105. 7 indexed citations
4.
Winkelmann, M., et al.. (2023). A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor. Frontiers in Bioengineering and Biotechnology. 11. 1107055–1107055. 21 indexed citations
5.
Rojewski, Markus, Ramin Lotfi, Cecilie Gjerde, et al.. (2019). Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. Cytotherapy. 21(4). 468–482. 34 indexed citations
6.
Rapp, Anna E., Ronny Bindl, Annika Erbacher, et al.. (2018). Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration. International Journal of Molecular Sciences. 19(9). 2526–2526. 16 indexed citations
7.
Klatte‐Schulz, Franka, Tanja Schmidt, Sven Scheffler, et al.. (2018). Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study. International Journal of Molecular Sciences. 19(1). 212–212. 57 indexed citations
8.
Groth, Christopher, Eva Altrock, Franz Jakob, et al.. (2017). A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow. Cancer Research. 78(1). 129–142. 30 indexed citations
9.
Barckhausen, Christina, et al.. (2016). GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor. Methods in molecular biology. 1416. 389–412. 26 indexed citations
10.
Fekete, Natalie, Daniel E. Furst, Markus Rojewski, et al.. (2014). Effect of High-Dose Irradiation on Human Bone-Marrow-Derived Mesenchymal Stromal Cells. Tissue Engineering Part C Methods. 21(2). 112–122. 38 indexed citations
11.
Veronesi, Elena, Alba Murgia, Anna Caselli, et al.. (2013). Transportation Conditions for Prompt Use of Ex Vivo Expanded and Freshly Harvested Clinical-Grade Bone Marrow Mesenchymal Stromal/Stem Cells for Bone Regeneration. Tissue Engineering Part C Methods. 20(3). 239–251. 35 indexed citations
12.
Fekete, Natalie, Markus Rojewski, Ramin Lotfi, & Hubert Schrezenmeier. (2013). Essential Components for Ex Vivo Proliferation of Mesenchymal Stromal Cells. Tissue Engineering Part C Methods. 20(2). 129–139. 39 indexed citations
13.
Yu, Qi, Dongsheng Jiang, Anca Sindrilaru, et al.. (2013). TSG-6 Released from Intradermally Injected Mesenchymal Stem Cells Accelerates Wound Healing and Reduces Tissue Fibrosis in Murine Full-Thickness Skin Wounds. Journal of Investigative Dermatology. 134(2). 526–537. 196 indexed citations
15.
Lotfi, Ramin, et al.. (2011). Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material. European Journal of Immunology. 41(7). 2021–2028. 46 indexed citations
16.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2010). Effects of nilotinib on regulatory T cells: the dose matters. Molecular Cancer. 9(1). 22–22. 22 indexed citations
18.
19.
Nolte, Florian, Oliver Friedrich, Markus Rojewski, et al.. (2004). Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)‐and anti‐CD95‐induced apoptosis in myeloid cells. FEBS Letters. 578(1-2). 85–89. 25 indexed citations
20.
Schrezenmeier, Hubert, et al.. (2000). Paroxysmal Nocturnal Haemoglobinuria: A Replacement of Haematopoietic Tissue?. Acta Haematologica. 103(1). 41–48. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026